New Marchand Institute Study Shows effect of a 20% intravenous fat emulsion therapy on IVF and ICSI

August 11, 2023Laparoscopy, Menopause, Minimally Invasive Surgery, Nitrous Oxide, OBGYN, UncategorizedBy Justin Clegg

Just published in the Journal of Clinical and Translational Research, The Marchand Institute’s new study on 20% intravenous fat emulsion therapy (also known as Intralipid^TM), shows the effect of this medication on patients who suffer from recurrent pregnancy loss (RPL) and recurrent implantation failure (RIF) who are seeking to conceive via invitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). The article is available online complete free at the US Government’s Pubmed website as well as Semantic Scholar^TM.